# US 2016/0354516 A1 · Minimally Invasive Method of Augmenting a Glans Penis with Intradermal Filler Material > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2016/0354516 A1 - Document ID: US20160354516A1 - Status: Published application - Kind: A1 - Application number: 15/173,701 - Filed: 2016-06-05 - Published: 2016-12-08 - Earliest claimed: 2015-06-05 - Inventors: Gary Chuang - Web page: https://patentgrep.com/patent/US20160354516A1 ## CPC - A61B 17/3468: {for implanting or removing devices, e.g. prostheses, implants, seeds, wires (devices for implanting seeds A61M37/0069)} - A61L 27/16: obtained by reactions only involving carbon-to-carbon unsaturated bonds - A61L 27/20: Polysaccharides - A61M 5/00: Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests (tube connectors, tube couplings, valves or branch units, specially adapted for medical use A61M39/00; containers specially adapted for medical or pharmaceutical purposes A61J1/00) - A61M 5/32: Needles; Details of needles pertaining to their connection with syringe or hub (infusion needles A61M5/158); Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles - A61L 2400/06: Flowable or injectable implant compositions - A61L 2430/34: for soft tissue reconstruction - A61M 2210/167: Penis - A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D) - A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K) - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} ## Abstract A method for augmenting the glans penis provides a minimally invasive introduction of injectable biocompatible material, including hyaluronic acid, to increase the girth of the glans penis while maintaining sensation in the penis. The method initially performs preoperative penile inspection of the girth of a penis. A biocompatible material is injected at a 12 o'clock, a 3 o'clock and 9 o'clock injection point relative to the glans penis. Where damage to the dorsal pedicle may occur, the injection points is at a 10'oclock and a 2 o'clock injection point. The biocompatible material is nontoxic and nonimmunogenic. The biocompatible can also be injected below the corona of the glans penis to create a mushroom effect causing nodules and pearls and intradermal injection causes blebs. Then, postoperative compressive dressing is applied to the penis. Then the penis is measured for postoperative changes in penile girth, and postoperative sexual satisfaction is recorded. ## Claims ### Claim 1 A method for augmenting the glans penis with biocompatible material, the method comprising: inspecting preoperative penile girth of a penis; injecting a biocompatible material into a fascial layer of a glans penis; providing bulk injection to create dermal nodules and blebs; applying postoperative compressive dressing to the penis; measuring postoperative changes in penile girth; and recording postoperative sexual satisfaction by patient. ### Claim 2 (depends on 1) The method of claim 1, wherein the step of injecting a biocompatible material into a fascial layer of a glans penis is performed with a needle or a cannula. ### Claim 3 (depends on 1) The method of claim 1, wherein the step of injecting a biocompatible material into a fascial layer of a glans penis, further includes performing a measured injection of the biocompatible material approximately at a 12 o'clock injection point, a 3 o'clock injection point, and a 9 o'clock injection point of the glans penis. ### Claim 4 (depends on 1) The method of claim 1, wherein the step of injecting a biocompatible material into a fascial layer of a glans penis, further includes performing a measured injection of the biocompatible material at a 12 o'clock injection point and a 3 o'clock injection point of the glans penis. ### Claim 5 (depends on 1) The method of claim 1, wherein the step of injecting a biocompatible material into a fascial layer of a glans penis, further includes performing a measured injection of the biocompatible material at a 12 o'clock injection point and a 9 o'clock injection point of the glans penis. ### Claim 6 (depends on 1) The method of claim 1, wherein the step of injecting a biocompatible material into a fascial layer of a glans penis, further includes performing a measured injection of the biocompatible material at a 3 o'clock injection point and a 9 o'clock injection point of the glans penis. ### Claim 7 (depends on 1) The method of claim 1, further comprising the step of inserting a graft into a fascial layer of the glans penis. ### Claim 8 (depends on 1) The method of claim 1, wherein the step of providing bulk injection to create dermal nodules and blebs comprises pearls and dermal fillers. ### Claim 9 (depends on 1) The method of claim 1, wherein the biocompatible material includes at least one member selected from the group consisting of: hyaluronic acid, calcium hydroxyapatite, poly-lactic acid, silicone, polymethylmethacrylate, cross-linked dextran, hydroxypropyl methylcellulose, physiological saline, and distilled water. ### Claim 10 A method for augmenting the glans penis with biocompatible material, the method comprising: inspecting preoperative penile girth of a penis; injecting a biocompatible material into a fascial layer of a glans penis approximately at a 12 o'clock injection point, a 3 o'clock injection point, and a 9 o'clock injection point on a glans penis; providing bulk injection to create dermal nodules and blebs; applying postoperative compressive dressing to the penis; inserting a graft into a fascial layer of the glans penis; measuring postoperative changes in penile girth; and recording postoperative sexual satisfaction by patient. ### Claim 11 (depends on 10) The method of claim 10, wherein the step of injecting a biocompatible material into a fascial layer of a glans penis, further includes performing a measured injection of the biocompatible material at a 12 o'clock injection point, a 3 o'clock injection point, and a 9 o'clock injection point of the glans penis. ### Claim 12 (depends on 10) The method of claim 10, wherein the step of providing bulk injection to create dermal nodules and blebs comprises pearls and dermal fillers. ### Claim 13 (depends on 10) The method of claim 10, wherein the biocompatible material includes at least one member selected from the group consisting of: hyaluronic acid, calcium hydroxyapatite, poly-lactic acid, silicone, polymethylmethacrylate, cross-linked dextran, hydroxypropyl methylcellulose, physiological saline, and distilled water. ### Claim 14 A method for augmenting the glans penis to create a mushrooming effect proximal to the glans penis, the method comprising: inspecting preoperative penile girth of a penis; injecting a biocompatible material below the corona of a glans penis; creating a mushrooming effect around the glans penis; providing bulk injection to create dermal nodules and blebs; applying postoperative compressive dressing to the penis; measuring postoperative changes in penile girth; and recording postoperative sexual satisfaction by patient. ### Claim 15 (depends on 14) The method of claim 14, wherein the step of injecting a biocompatible material below the corona of a glans penis is performed with a needle or a cannula. ### Claim 16 (depends on 14) The method of claim 14, wherein the mushrooming effect comprises collagen pearls, microbeads, and blebs that form below the corona of the glans penis. ### Claim 17 (depends on 14) The method of claim 14, wherein the step of injecting a biocompatible material below the corona of a glans penis, further includes performing a measured injection of the biocompatible material at a 10 o'clock injection point and a 2 o'clock injection point of the glans penis. ### Claim 18 (depends on 14) The method of claim 14, wherein the biocompatible material includes at least one member selected from the group consisting of: hyaluronic acid, calcium hydroxyapatite, poly-lactic acid, silicone, polymethylmethacrylate, cross-linked dextran, hydroxypropyl methylcellulose, physiological saline, and distilled water. ### Claim 19 (depends on 14) The method of claim 14, further comprising the step of inserting a graft into a fascial layer of the glans penis. ### Claim 20 (depends on 14) The method of claim 14, wherein the step of providing bulk injection to create dermal nodules and blebs comprises pearls and dermal fillers.